[U.S. Food and Drug Administration]

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policymakers with persons outside the executive branch of the Federal Government.

Week of April 17- April 23, 1998

FDA Official and Title Date and SiteOther FDA ParticipantsNon-FDA ParticipantsSubject
Michael A. Friedman, M.D., Lead Deputy Commissioner 4/21 Washington, D.C. Lorrie McHugh, and others Vice President Al Gore, and others REGO Press Conference
Michael A. Friedman, M.D., Lead Deputy Commissioner 4/22 Capitol Hill Diane Thompson, and others Rep. Dan Burton Congressional Hearing
Michael A. Friedman, M.D., Lead Deputy Commissioner 4/23 FDA-Rock. Sharon Smith Holston Thomas Kosmo, The Mentor Group Discussion of Forum for US-EU Legal-Economic Affairs mtg. To be held in September of 1999
Stuart L. Nightingale, Associate Commissioner for Health Affairs 4/20 Rockville Dr. Michelle Limoli, Nick Reuter, Ron Wilson Reps. From Whitehall-Robins Healthcare; Warner Lambert, NDMA WHO Expert Committee on Drug Dependence Review of Ephedrine
Stuart L. Nightingale, Associate Commissioner for Health Affairs 4/21 Silver Spring, MD Dr. Michelle Limoli Linda Vogel, DHHS, Reps. From Catholic Medical Mission Board WHO Guidelines on Drug Donations
Kathryn C. Zoon, Ph.D., Director, CBER 4/20 Bethesda, MD other CBER staff PhRMA Board Of Directors Twice yearly liaison to discuss areas of mutual interest
David Feigal, M.D., Deputy Director for Medicine, CBER 4/20 Bethesda, MD other FDA staff AATB members Discuss questions related to implementation of Final Rule for Human Tissue Intended for Transplantation

Return to FDA News Page

April 27, 1998